Investigation into the Biological Impact of Block Size on Cathepsin S-Degradable HPMA Copolymers

Abstract

N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers have been studied as an efficient carrier for drug delivery and tumor imaging. However, as with many macromolecular platforms, the substantial accumulation of HPMA copolymer by the mononuclear phagocyte system (MPS)-associated tissues, such as the blood, liver and spleen, has inhibited its clinical translation. Our laboratory is pursuing approaches to improve the diagnostic and radiotherapeutic effectiveness of HPMA copolymers by reducing the non-target accumulation. Specifically, we have been investigating the use of a cathepsin S (Cat S)-cleavable peptidic linkers to degrade multi-block HPMA copolymers to increase MPS-associated tissue clearance. In this study, we further our investigation into this area by exploring the impact of copolymer block size on the biological performance of Cat S-degradable HPMA copolymers. Using a variety of in vitro and in vivo techniques, including dual labeling of the copolymer and peptide components, we investigated the constructs using HPAC pancreatic ductal adenocarcinoma models. The smaller copolymer block size (S-CMP) demonstrated significantly faster Cat S cleavage kinetics relative to the larger system (L-CMP). Confocal microscopy demonstrated that both constructs could be much more efficiently internalized by human monocyte-differentiated macrophage (hMDM) compared to HPAC cells. In the biodistribution studies, the multi-block copolymers with a smaller block size exhibited faster clearance and lower non-target retention while still achieving good tumor targeting and retention. Based on the radioisotopic ratios, fragmentation and clearance of the copolymer constructs was higher in the liver compared to the spleen and tumor. Overall, these results indicate that block size plays an important role in the biological performance of Cat S-degradable polymeric constructs.

Protease-triggered bioresponsive drug delivery for the targeted theranostics of malignancy

“…However, this tendency did not affect the targeting and nanoenrichment at tumor sites. This discovery revealed the implication of nanoprofile for their internal functioning and biological performance, and provided a basis for designing nanotheranostics with a reasonable appearance 231 . Considering the overexpression and co-promotion of cathepsins S and L in tumor progression, they were focused as co-targets for enhanced diagnostic events and drug release.…”

Improved Immuno-PET Imaging of HER2-Positive Tumors in Mice: Urokinase Injection-Triggered Clearance Enhancement of 64Cu-Trastuzumab

“…Therefore, the tumor accumulation and imaging contrast could be improved further. Moreover, nontarget accumulation in the liver and spleen, which are components of the mononuclear phagocyte system, was recently reported to be reduced by using endogenous cathepsin S-cleavable linkers in single photon emission computerized tomography. − By a combined approach to reduce blood radioactivity and nontarget tissue accumulation, immuno-PET imaging with more improved contrast may be achieved …”

Exploration of a Pretargeted Theranostic Copolymer Employing Inverse Electron-Demand Diels–Alder Conjugation in Ovarian Cancer

“…The radioactivity in the tissues, carcasses, and bedding was measured using a well counter. The resulting gamma energy spectra were utilized to discriminate between 177 Lu and 111 In present in each sample, analogous to our previous report . This data determined each isotope’s percent injected dose (%ID) and %ID/g.…”